Identification of an Immunogenic DKK1 Long Peptide for Immunotherapy of Human Multiple Myeloma

Haematologica - Italy
doi 10.3324/haematol.2019.236836
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Ferrata Storti Foundation (Haematologica)

Related search

Editorial: Immunotherapy in Multiple Myeloma

Frontiers in Immunology
AllergyImmunology
2019English

Cell-Based Immunotherapy Approaches for Multiple Myeloma

British Journal of Cancer
Cancer ResearchOncology
2018English

Downregulation of MicroRNA-152 Contributes to High Expression of DKK1 in Multiple Myeloma

RNA Biology
Cell BiologyMolecular Biology
2015English

Current Developments in Immunotherapy in the Treatment of Multiple Myeloma

Cancer
Cancer ResearchOncology
2018English

Investigational Agents in Immunotherapy: A New Horizon for the Treatment of Multiple Myeloma

British Journal of Haematology
Hematology
2018English

Mass Spectrometry-Based Identification of a B-Cell Maturation Antigen-Derived T-Cell Epitope for Antigen-Specific Immunotherapy of Multiple Myeloma

Blood Cancer Journal
OncologyHematology
2020English

CAR T Cell Immunotherapy for Multiple Myeloma. A Review of Current Data and Potential Clinical Applications

American Journal of Hematology
Hematology
2019English

Novel Strategies in the Treatment of Multiple Myeloma: From Proteasome Inhibitors to Immunotherapy

Journal of Cell Science & Therapy
2010English

Frontline Therapy in Multiple Myeloma: Fast Start for a Long Game

The Lancet Haematology
Hematology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy